IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sucampo Pharmaceuticals Inc

CUSIP: 864909106 | 391 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

Glenmede Trust Co NA461
0.0% of portfolio›$8
IFP Advisors, Inc384
0.0% of portfolio›$7
Advantage Investment Management, LLC311
0.0% of portfolio›$6
StyleTurnoverLocationFiled
Glenmede Trust Co NA
461$80.0%CoreLowPhiladelphia, PA2018-05-15
IFP Advisors, Inc
384$70.0%GrowthLowTampa, FL2019-06-03
Advantage Investment Management, LLC
311$60.0%N/AN/ACedar Rapids, IA2018-05-15